Skip to main content
. Author manuscript; available in PMC: 2012 Dec 1.
Published in final edited form as: Mol Carcinog. 2011 Mar 11;50(12):931–944. doi: 10.1002/mc.20758

Table 1. Cystectomy patient characteristics.

TOTAL PATIENTS, n= (%) 72 (100)
AGE, years
   mean +/− s. d.
   median
   range
66.4 +/− 10.0
66.6
43.3 – 88.8
GENDER, n= (%)
   Female
   Male
21 (29)
51 (71)
RACE, n= (%)
   Caucasian
   Other
66 (92%)
6 (8%)
BMI, kg/m2
   mean +/− s. d.
   median
26. 8 +/− 4. 8
26. 5
SMOKING HISTORY, n= (%) 56 (74)
ACTIVE SMOKER, n= (%) 15 (21)
PRIOR PELVIC IRRADIATION, n= (%) 8 (11)
PRIOR INTRAVESICAL CHEMOTHERAPY, n= (%) 21 (29)
PRIOR NEOADJUVANT SYSTEMIC CHEMOTHERAPY, n= (%) 11 (15)
PRE-OPERATIVE HYDRONEPHROSIS, n= (%) 20 (28)
PATHOLOGIC STAGE, n= (%)
   pT0
   pTa
   pTis
   pT1
   pT2
   pT3
   pT4
13 (18)
9 (13)
11 (15)
7 (10)
10 (15)
11 (15)
11 (15)
LYMPH NODE METASTASES, n= (%) 18 (25)
N-STAGE
   N1
   N2
   N3
10 (14)
5 (7)
3 (4)
LYMPHOVASCULAR INVASION, n= (%) 15 (21)
PERINEURAL INVASION, n= (%) 6 (8)
CONCOMITANT CARCINOMA IN SITU (CIS), n= (%) 34 (47)
POST-OPERATIVE FOLLOW UP INTERVAL, months
   mean +/− s. d.
   median
26. 3 +/− 21. 2
21. 2
POST-OPERTATIVE RECURRENCE, n= (%) 19 (26)
POST-OPERATIVE DEATH FROM BLADDER CANCER, n= (%) 15 (21)